Neurobiological, Neuropsychological,Linguistic and Gestural Processes and Phenomena in Individuals With Alexithymia (ALEX)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00830752|
Recruitment Status : Unknown
Verified January 2009 by Charite University, Berlin, Germany.
Recruitment status was: Not yet recruiting
First Posted : January 28, 2009
Last Update Posted : January 28, 2009
The syndrome of extremely restricted emotional competence, alexithymia, was originally conceptualized in psychoanalytic research and is now empirically and experimentally studied in clinical psychology and psychological medicine within the context of emotion regulation using neuroscientific techniques. Alexithymia refers to an individual's inability or impaired ability to name or express feelings and to distinguish them from the physical consequences of an acute or chronic stress reaction. Modern "brain-body-interface" research suggests that alexithymia represents a complex deficiency in cognitive processing and emotional regulatory processes. The neurobiological basis is assumed to be a preconscious, automatic and involuntary information transfer to the amygdalae of acquired representations of emotional contents stored in ventromedial prefrontal cortical areas.
Alexithymia is not just "emotional coldness", i.e. a limited emotionality, but essentially the detachment of feelings from language. In alexithymia the link between affective phenomena and language, understood as media-supported sign practices, is insufficient or even absent.
The purpose of our observational study is to better understand the neurobiological and neuropsychological as well as linguistic and gestural processes and determinants of this phenomenon
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||70 participants|
|Official Title:||Understanding Alexithymia|
|Study Start Date :||February 2009|
|Estimated Primary Completion Date :||August 2009|
|Estimated Study Completion Date :||December 2009|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00830752
|Charite-Dept. of Psychiatry-Campus Benjamin Franklin||Not yet recruiting|
|Berlin, Germany, 14050|
|Contact: Isabella JE Heuser, MD, PhD ++493084458701 firstname.lastname@example.org|
|Contact: Claudia Crayen, MS ++493083857839 email@example.com|
|Sub-Investigator: Malek Bajbouj, MD|